Manuscripts
Showing 1589 manuscripts.
Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens
Citation
Christopher Alba, Shelly Malhotra, Stephanie Horsfall, Matthew E. Barnhart, Adrie Bekker, Katerina Chapman, Coleen K. Cunningham, Patricia E. Fast, Genevieve G. Fouda, Kenneth A. Freedberg, Ameena Goga, Lusine R. Ghazaryan, Valériane Leroy, Carlyn Mann, Margaret M. McCluskey, Elizabeth J. McFarland, Vincent Muturi-Kioi, Sallie R. Permar, Roger Shapiro, Devin Sok, Lynda Stranix-Chibanda, Milton C. Weinstein, Andrea L. Ciaranello, Caitlin M. Dugdale. Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens. PLoS One. 2025. 20: e0318940. PMID: 40106399Year
2025
Journal
PLoS One
Study
P1112
Influence of Distinct Maternal Cytomegalovirus-Specific Neutralizing and Fc Receptor-Binding Responses on Congenital Cytomegalovirus Transmission in HIV-Exposed Neonates
Citation
Itzayana G Miller, Aakash Mahant Mahant, Jennifer A Jenks, Eleanor C Semmes, Eric Rochat, Savannah L Herbek, Caroline Andy , Nicole S Rodgers, Justin Pollara, Linda M Gerber, Betsy C Herold, Sallie R Permar. Influence of Distinct Maternal Cytomegalovirus-Specific Neutralizing and Fc Receptor-Binding Responses on Congenital Cytomegalovirus Transmission in HIV-Exposed Neonates. Viruses. 2025. 17: 325. PMID: 40143253Year
2025
Journal
Viruses
ART-free HIV-1 remission in children with in-utero HIV-1 after very early ART (IMPAACT P1115): a multicentre, open-label, phase 1/2 proof-of-concept study
Citation
Deborah Persaud, Anne Coletti, Bryan S. Nelson, Jennifer Jao, Edmund V. Capparelli, Diane Costello, Camlin Tierney, Adeodata R. Kekitiinwa, Teacler Nematadzira, Boniface N. Njau, John Moye, Patrick Jean-Philippe, Violet Korutaro, Annet Nalugo, Tapiwa Mbengeranwa, Tinashe Chidemo, Blandina T. Mmbaga, Philoteus A. Sakasaka, Mark Cotton, Cheryl Jennings, Carly Hoffmann, Laura Hovind, Yvonne Bryson, Ellen G Chadwick, IMPAACT P1115 Study Team. ART-free HIV-1 remission in children with in-utero HIV-1 after very early ART (IMPAACT P1115): a multicentre, open-label, phase 1/2 proof-of-concept study. Lancet HIV. 2025. 12: e743-e752. PMID: 41015049Year
2025
Journal
Lancet HIV
Study
P1115
Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During
Pregnancy and the Postpartum Period: Results From IMPAACT P1026s
Citation
Jennifer A. Hughes, Flynn McMorrow, Kristina M. Brooks, Mauricio Pinilla, Lee Fairlie, James S. Ngocho, Alice Stek, Brookie M. Best, Mark Mirochnick, Lubbe Wiesner, Kathleen George, Kevin Knowles, Renee Browning, Tara DeYampert, Anneke C. Hesseling, Eric Decloedt, David E. Shapiro, Ahizechukwu C. Eke, IMPAACT P1026s Protocol Team. Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026s. Journal of Infectious Diseases. 2025. 233: 16-26. PMID: 41165222Year
2025
Journal
Journal of Infectious Diseases
Study
P1026S
Breast Milk Transfer and Infant Exposures to Dolutegravir, Tenofovir, and Tenofovir Alafenamide: Results from IMPAACT 2010/VESTED
Citation
Tk Nguyen, Jung-Woo Chae, Lauren Ziemba, Anne Coletti, Kevin Knowles, Benjamin Johnston, Patrick Jean-Philippe, Tsungai Mhembere, Tariro Chawana, Deo Wabwire, Violet Korutaro, Sikhulile Moyo, Patricia Mandima, Siphokazi Sibisi, Avy Violari, Sherika Hanley, Blandina Mmbaga, Gaerolwe Masheto, Ponego Ponatshego, Gerhard Theron, Shilpa N Naik, Roger Shapiro, Shahin Lockman, Lameck Chinula, Jeremiah D. Momper, IMPAACT 2010/VESTED Protocol Team. Breast Milk Transfer and Infant Exposures to Dolutegravir, Tenofovir, and Tenofovir Alafenamide: Results from IMPAACT 2010/VESTED. Journal of Acquired Immune Deficiency Syndromes. 2025. Online ahead of printPMID: 41195894Year
2025
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
IMPAACT 2010
Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices during Pregnancy and Postpartum
Citation
Yifan Yu, Kristina M. Brooks, Gustavo F. Doncel, Brookie M. Best, Mark A. Marzinke, Mark Mirochnick, Peter Anderson, Landon Myer, Connie Celum, Renee Heffron, Jenell Coleman, Dvora Joseph Davey, Craig W. Hendrix, Jeremiah D. Momper, Robert Bies, Rachel K. Scott. Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices during Pregnancy and Postpartum. Clinical Pharmacokinetics. 2025. 65: 133-148. PMID: 41222898Year
2025
Journal
Clinical Pharmacokinetics
Study
P1026S, IMPAACT 2026
Are Family Factors Differentially Associated with Externalizing Symptoms Among Youth with Perinatally Acquired HIV?
Citation
Deborah A G Drabick, Rafaella J Jakubovic, Abbey L Friedman, Valerie S Everett, George O Emory, Marianela Rosales Gerpe, Katherine M Deloreto, Aidan P Campagnolio, Mary Katherine Galante, Sharon Nachman, Kenneth D Gadow. Are Family Factors Differentially Associated with Externalizing Symptoms Among Youth with Perinatally Acquired HIV?. Child Psychiatry & Human Development. 2025. 56: 1559-1572. PMID: 38261149Year
2025
Journal
Child Psychiatry & Human Development
Study
P1055
Postpartum maternal monitoring for renal safety related to tenofovir exposure during breastfeeding in the PROMISE 1077BF randomized trial
Citation
Kristin Baltrusaitis, Camlin Tierney, Mary Glenn Fowler, Maxensia Owor, Teacler G. Nematadzira, Lynette Nyakudya, Haseena Cassim, Jeanne de Jager, Kathleen George, Barbara Heckman, Kevin Knowles, Renee Browning, George K. Siberry, Taha E. Taha, Lynda Stranix-Chibanda, PROMISE P1084s Study Team. Postpartum maternal monitoring for renal safety related to tenofovir exposure during breastfeeding in the PROMISE 1077BF randomized trial. Journal of AIDS. 2025. PMID: 41474755Year
2025
Journal
Journal of AIDS
Study
P1084s
Use of a Medication Management Algorithm in Depressed Youth Living with HIV: Secondary analysis of a multi-site randomized controlled trial
Citation
Graham J. Emslie, Beth D. Kennard, Kristin Baltrusaitis, Sophia M. Jones, Jessica M. Jones, Jaime Deville, Kathy Pitts, David E. Shapiro, Allison Eliscu, Larry K. Brown. Use of a Medication Management Algorithm in Depressed Youth Living with HIV: Secondary analysis of a multi-site randomized controlled trial. Journal of Child and Adolescent Psychopharmacology. 2025. PMID: 41182169Year
2025
Journal
Journal of Child and Adolescent Psychopharmacology
Study
IMPAACT 2002
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study
Citation
Mark F Cotton, Patrick Jean-Philippe, Anne Coletti, Ellen G Chadwick, Jennifer Jao, Stephen A Spector, Mark Mirochnick, Edmund V Capparelli, Diane Costello, Joseph Szewczyk, Nicol Nicodimus, Lynda Stranix-Chibanda, Adeodata R Kekitiinwa, Violet Korutaro, Deborah Persaud, Christina Reding, Yvonne Bryson, Mary N Carrington, Bryan S Nelson, Sai Majji, Camlin Tierney, Dwight E Yin. HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study. Lancet HIV. 2024. 23: 2352-3018. PMID: 38061376Year
2024
Journal
Lancet HIV
Study
P1115